Hi everyone,
Can anyone comment on the article I have copied below? It basically states that the Hida Scan w/cck is worthless in that it was not predictive of whether or not a patient would benefit from having their gallbladder removed - regardless of how low thier ejection fraction was, or how much in the way of symptoms it provoked.
It is a pretty large study done by a reputable medical center, so I'm on the fence about whether or not to have this test. I currently have elevated pancreatic enzymes (6+ weeks), abdominal pain, difficulty eating and severe rib and shoulder pain on the right. MRI and MRCP only picked up an 8mm cyst in the gb. Not sure what to do and really thought the Hida with cck would be valuable information. No I wonder.
Thanks for your thoughts!
RobynLee
Laparoscopic cholecystectomy for acalculous gallbladder disease
ROB A. FULLER, MD, JOSEPH A. KUHN, MD, TAMMY L. FISHER, RN, THOMAS W. NEWSOME, MD, BRUCE A. SMITH, MD, AND RONALD C. JONES, MD
From the Department of Surgery, Baylor University Medical Center, Dallas, Texas.
Dr. Fuller is now a surgical oncology fellow at the City of Hope National Medical Center, Duarte, California.
This work was supported in part by a grant from the Seeger Foundation.
Corresponding author: Rob A. Fuller, MD, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, California 91010.
Use of laparoscopic cholecystectomy (LC) to treat patients with symptoms due to gallstone disease is well established. However, use of LC for patients with acalculous gallbladder disease remains controversial. In this study, we examined the use of hepatobiliary iminodiacetic acid (HIDA) scans with cholecystokinin (CCK) infusion to identify patients with acalculous gallbladder disease who would benefit from LC. From December 1991 to February 1997, 4480 patients underwent cholecystectomy at Baylor University Medical Center, including 72 patients who underwent LC for acalculous disease following preoperative HIDA scan. We retrospectively analyzed their preoperative symptoms and workup. Follow-up was obtained by telephone questionnaire in 59 of 72 patients (82%). Overall, 48 of 59 patients (82%) reported an excellent outcome following LC. We found no significant difference in outcome in patients who underwent HIDA scan with CCK infusion, regardless of gallbladder ejection fraction or exacerbation of symptoms caused by the infusion. Preoperative symptom complex was also not predictive of postoperative outcome. LC is an effective treatment for patients with acalculous gallbladder disease. A preoperative HIDA scan with CCK infusion does not accurately predict treatment success or failure. Patients with a normal ejection fraction and absence of symptoms from a HIDA scan can still have excellent relief of symptoms after LC.
DISCUSSION
LC is an effective treatment for biliary tract disease related to gallstones, with resolution of symptoms obtained in approximately 95% of patients (2). The reported resolution of symptoms following cholecystectomy for acalculous gallbladder disease is likewise high, ranging from 82% to 100% (4-14). Even with these excellent results, some authors suggest performing cholecystectomy for acalculous disease only when HIDA scans with CCK infusion demonstrate an abnormally low ejection fraction (30% to 50%) and/or recurrence of symptoms with CCK infusion (5-7, 9, 11, 12). Others have evaluated the usefulness of HIDA scans with CCK and found that they were not accurate predictors of patient outcome (4, 10). All agree that the diagnosis is difficult to make and requires a thorough search for other etiologies of the patient's complaints prior to proceeding with cholecystectomy.
In our study, 72 patients who had acalculous gallbladder disease, underwent HIDA scans with CCK infusion, and were subsequently treated with LC were evaluated, with complete follow-up in 59 patients. The overall response to LC is in agreement with several prior studies; 82% had either markedly improved symptoms or complete relief of symptoms.
Differences in this study compared with others are the wide range of ejection fractions measured prior to LC (0% to 97%) and the inability of the HIDA scan with CCK infusion to accurately differentiate which patients would experience excellent outcomes from their surgery vs those who would derive little or no benefit from LC. Patients with normal gallbladder ejection fractions (>30%) had the same outcome as those with abnormal gallbladder ejection fractions (<30%). The surgeons in this report have traditionally used a conservative ejection fraction
cutoff of 30% to help determine patients who have poorly functioning gallbladders and who would potentially benefit from LC. However, an abnormal ejection fraction <35% or <40% also did not help predict which patients would benefit from LC.
In addition, exacerbation of symptoms during injection of CCK did not accurately predict resolution of symptoms after LC. This result was not affected by the method of CCK infusion. In several studies, pain with CCK infusion has been used prior to proceeding to LC (4, 5, 7, 10). However, several authors have also noted that reproducible symptoms after CCK injection are not a reliable predictor of excellent outcome following LC (4, 10). In the present study, 7 patients had a fast bolus injection of CCK instead of a slow continuous infusion of CCK. Return of symptoms after this bolus injection was not significantly different at predicting improved outcome when compared with the slower CCK infusion.
Since its introduction by Krishnamurthy, the HIDA scan with CCK has been touted as the diagnostic procedure of choice in the group of patients with acalculous gallbladder disease (3). Clearly, the HIDA scan provides physiologic and anatomic information about biliary excretion. In this study if only those patients with abnormal ejection fractions and reproducible symptoms with CCK injection were analyzed, the HIDA scan would seem to be a good predictor for excellent outcomes after LC. However, this study represents one of the largest series of patients with normal HIDA scans who underwent LC. Surprisingly, a normal HIDA scan did not predict a lower success rate for LC.
As technology advances and the indications for LC broaden, there is still no accurate test to predict which patients with presumed acalculous gallbladder disease will benefit from LC (15). When an exhaustive workup in a patient with signs and symptoms consistent with acalculous gallbladder disease is negative, clinical acumen remains the only reliable test to determine those patients who will benefit from LC.